Ambrx Biopharma PE Ratio 2020-2022 | AMAM
Current and historical p/e ratio for Ambrx Biopharma (AMAM) from 2020 to 2022. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. Ambrx Biopharma PE ratio as of March 24, 2023 is 0.00.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| Ambrx Biopharma PE Ratio Historical Data |
| Date |
Stock Price |
TTM Net EPS |
PE Ratio |
| 2023-03-24 |
9.29 |
|
inf |
| Sector |
Industry |
Market Cap |
Revenue |
| Medical |
Medical - Biomedical and Genetics |
$0.359B |
$0.007B |
|
Ambrx Biopharma Inc. is a clinical stage biopharmaceutical company using an expanded genetic code technology platform to discover and develop Engineered Precision Biologics. Ambrx Biopharma Inc. is based in SAN DIEGO.
|
